Using GSEA, we found that genes upregulated in response to BMI1 knockdown in cancer cells were also upregulated in PTC596 and A1016-treated GBM cells, suggesting efficient drug-mediated BMI1 inhibition (Fig. S6A, B). Here, BMI1 is linked to glioblastoma.